{"id":64008,"date":"2024-08-08T05:25:23","date_gmt":"2024-08-08T05:25:23","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&p=64008"},"modified":"2026-05-16T05:24:27","modified_gmt":"2026-05-16T05:24:27","slug":"hucog-10000iu-injection","status":"publish","type":"product","link":"https:\/\/medsbase.com\/nl\/hucog-10000iu-injection\/","title":{"rendered":"HUCOG 10000IU Injectie"},"content":{"rendered":"
\n

Snelle antwoord<\/h3>\n

HUCOG 10000IU Injectie<\/strong> \u2014 HUCOG 10000 IU Injection is a human chorionic gonadotropin (hCG) preparation used in fertility treatment for women (ovulation trigger and luteal support) and in selected hypogonadism \/ cryptorchidism protocols in men. Hospital or specialist administration recommended.<\/p>\n<\/div>\n

Substitution Notice:<\/strong> All HUCOG 10000IU Injection orders are currently being fulfilled with ZyHCG HP 10000IU Injectie<\/a> (same active ingredient, same strength, same manufacturer group) until cold-chain shipping for HUCOG is established.<\/div>\n
\nWat u krijgt bij MedsBase:<\/strong> WHO-GMP gecertificeerde fabrikant \u00b7 Discrete verpakking \u00b7 Wereldwijde verzending \u00b7 1.400+ geverifieerde klantbeoordelingen<\/a>\n<\/div>\n

\ud83d\udce6 Elke bestelling is gedekt door onze Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\n

Waarom bestellen bij MedsBase<\/h3>\n

Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen \u2014 geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor \u2014 nooit \u201cMedsBase\u201d of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.<\/p>\n

What Is HUCOG 10000IU?<\/h2>\n

HUCOG 10000IU is a highly purified Human Chorionic Gonadotropin (HCG) injection manufactured by Bharat Serums & Vaccines Ltd.<\/strong>, one of India’s largest and most established biopharmaceutical companies with over six decades of experience in serum-based biologics. Each vial contains 10,000 International Units of urinary-derived HCG in lyophilized (freeze-dried) powder form, supplied with a sterile solvent ampoule for reconstitution.<\/p>\n

HCG is a glycoprotein hormone naturally produced during pregnancy. Its molecular structure closely resembles luteinizing hormone (LH), which allows it to bind to LH receptors and stimulate the same downstream effects \u2014 ovulation in women and testosterone production in men. This dual mechanism makes HUCOG 10000IU one of the most versatile injectable hormones used in reproductive medicine and endocrinology.<\/p>\n

Bharat Serums manufactures HUCOG under strict WHO-GMP conditions. The urinary extraction process uses multiple chromatographic purification steps to isolate HCG while removing impurities, resulting in a product with high bioactivity and low immunogenicity.<\/p>\n

Uses of HUCOG 10000IU<\/h2>\n

HUCOG 10000IU is prescribed across a range of clinical indications in both women and men. For a comprehensive overview, see our guide on HCG injection uses, dosage, and side effects<\/a>.<\/p>\n

Female Fertility: Ovulation Trigger<\/h3>\n

The most common use of HUCOG 10000IU is as a “trigger shot” in assisted reproduction. After controlled ovarian stimulation with FSH-based medications (such as Gonal-F or Menopur), a single injection of 5,000 to 10,000 IU of HCG is administered to induce final follicular maturation and ovulation. This is standard protocol in both IUI<\/strong> (intrauterine insemination) and IVF<\/strong> (in vitro fertilization) cycles. Ovulation typically occurs 36 to 40 hours after the trigger injection, allowing precise timing of insemination or egg retrieval.<\/p>\n

HCG is also used for luteal phase support<\/strong> after embryo transfer, where repeated lower doses help maintain progesterone levels during the critical implantation window.<\/p>\n

Male Hypogonadism<\/h3>\n

In men with hypogonadotropic hypogonadism \u2014 where the pituitary gland fails to produce adequate LH \u2014 HCG acts as a direct LH substitute. It stimulates Leydig cells in the testes to produce testosterone endogenously, often restoring both testosterone levels and spermatogenesis without the fertility-suppressing effects of exogenous testosterone.<\/p>\n

TRT Adjunct (Testosterone Replacement Therapy)<\/h3>\n

Men on testosterone replacement therapy commonly experience testicular atrophy and suppressed sperm production because exogenous testosterone shuts down the hypothalamic-pituitary-gonadal axis. Co-administering low-dose HCG (typically 250 to 500 IU two to three times per week) maintains intratesticular testosterone production, preserves testicular volume, and supports ongoing fertility \u2014 a significant concern for younger men on TRT.<\/p>\n

Cryptorchidism<\/h3>\n

In prepubertal boys with undescended testes, HCG therapy can stimulate testicular descent by promoting testosterone production within the testes. This non-surgical approach is typically attempted before orchiopexy and is most effective when the testes are palpable in the inguinal canal.<\/p>\n

Post-Cycle Therapy (PCT)<\/h3>\n

After a cycle of anabolic steroids, endogenous testosterone production is suppressed. HCG is used during the early phase of post-cycle therapy to rapidly restore testicular function and testosterone output before transitioning to selective estrogen receptor modulators (SERMs) such as clomiphene or tamoxifen for full hypothalamic-pituitary recovery.<\/p>\n

Dosage by Indication<\/h2>\n

The following table summarizes standard HUCOG dosing protocols. All doses should be individualized under medical supervision.<\/p>\n\n\n\n\n\n\n\n\n\n\n
Indicatie<\/th>\nDosering<\/th>\nFrequentie<\/th>\nDuur<\/th>\n<\/tr>\n<\/thead>\n
Female ovulation trigger<\/td>\n5,000 – 10,000 IU<\/td>\nSingle injection<\/td>\nOne-time (per cycle)<\/td>\n<\/tr>\n
Luteale fase ondersteuning<\/td>\n5,000 IU<\/td>\nEvery 3 – 4 days<\/td>\nUp to 3 injections<\/td>\n<\/tr>\n
Male hypogonadism<\/td>\n1,000 – 2,000 IU<\/td>\n2 – 3x per week<\/td>\n3 – 6 months<\/td>\n<\/tr>\n
TRT adjunct<\/td>\n250 – 500 IU<\/td>\n2 – 3x per week<\/td>\nOngoing (with TRT)<\/td>\n<\/tr>\n
Cryptorchidism<\/td>\n500 – 1,000 IU<\/td>\n2 – 3x per week<\/td>\n4 – 6 weeks<\/td>\n<\/tr>\n
Post-cycle therapy (PCT)<\/td>\n1,000 – 2,000 IU<\/td>\nEvery other day<\/td>\n2 – 3 weeks<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

How to Administer HUCOG 10000IU<\/h2>\n

HUCOG 10000IU is supplied as a lyophilized powder in a glass vial with a separate ampoule of bacteriostatic water or sterile sodium chloride solution. For detailed step-by-step mixing instructions, see our guide on how to mix HCG (Human Gonadotropin)<\/a>.<\/p>\n

Reconstitution<\/h3>\n
    \n
  1. Wash hands thoroughly and clean the vial stopper and ampoule neck with an alcohol swab.<\/li>\n
  2. Snap open the solvent ampoule and draw the entire contents into a syringe.<\/li>\n
  3. Inject the solvent slowly into the HUCOG powder vial, directing the stream against the glass wall (not directly onto the powder) to avoid excessive foaming.<\/li>\n
  4. Swirl gently until the powder dissolves completely. Do not shake. The resulting solution should be clear and colorless.<\/li>\n<\/ol>\n

    Injection Route<\/h3>\n

    HUCOG 10000IU may be administered by intramuscular (IM)<\/strong> of subcutaneous (SC)<\/strong> injection. IM injection is the traditional route, typically into the upper outer quadrant of the gluteal muscle or the lateral thigh (vastus lateralis). SC injection into abdominal fat is increasingly common, particularly for lower-dose protocols such as TRT adjunct dosing, and studies show comparable bioavailability between the two routes.<\/p>\n

    Storage After Reconstitution<\/h3>\n